171 related articles for article (PubMed ID: 34095772)
1. Targeting Chromatin Regulation in Acute Myeloid Leukemia.
Richardson SE; Huntly BJP
Hemasphere; 2021 Jun; 5(6):e589. PubMed ID: 34095772
[No Abstract] [Full Text] [Related]
2. Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with
Rausch J; Dzama MM; Dolgikh N; Stiller HL; Bohl SR; Lahrmann C; Kunz K; Kessler L; Echchannaoui H; Chen CW; Kindler T; Döhner K; Burrows F; Theobald M; Sasca D; Kühn MWM
Haematologica; 2023 Oct; 108(10):2837-2843. PubMed ID: 37102614
[No Abstract] [Full Text] [Related]
3. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions.
Radzisheuskaya A; Peña-Rømer I; Lorenzini E; Koche R; Zhan Y; Shliaha PV; Cooper AJ; Fan Z; Shlyueva D; Johansen JV; Hendrickson RC; Helin K
EMBO J; 2023 Dec; 42(24):e114221. PubMed ID: 37987160
[TBL] [Abstract][Full Text] [Related]
4. [Research Progress on the Role of Chromatin Remodeling Factor BRG1 in Acute Myeloid Leukemia].
Gao S; Xu XJ; Zhang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):930-3. PubMed ID: 27342536
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy.
Maher M; Diesch J; Le Pannérer MM; Buschbeck M
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917538
[TBL] [Abstract][Full Text] [Related]
6. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
Elife; 2020 Jan; 9():. PubMed ID: 31985402
[TBL] [Abstract][Full Text] [Related]
7. Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.
Piazza F; Semenzato G
Expert Rev Anticancer Ther; 2004 Jun; 4(3):387-400. PubMed ID: 15161438
[TBL] [Abstract][Full Text] [Related]
8. Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis.
Wang J; Li Y; Wang P; Han G; Zhang T; Chang J; Yin R; Shan Y; Wen J; Xie X; Feng M; Wang Q; Hu J; Cheng Y; Zhang T; Li Y; Gao Z; Guo C; Wang J; Liang J; Cui M; Gao K; Chai J; Liu W; Cheng H; Li L; Zhou F; Liu L; Luo Y; Li S; Zhang H
Cell Stem Cell; 2020 Jul; 27(1):81-97.e8. PubMed ID: 32402251
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia.
Lu R; Wang GG
Front Oncol; 2017; 7():241. PubMed ID: 29075615
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia.
Xu X; Schneider B
Cell Oncol (Dordr); 2019 Apr; 42(2):117-130. PubMed ID: 30446944
[TBL] [Abstract][Full Text] [Related]
11. Molecular regulators of HOXA9 in acute myeloid leukemia.
Aryal S; Zhang Y; Wren S; Li C; Lu R
FEBS J; 2023 Jan; 290(2):321-339. PubMed ID: 34743404
[TBL] [Abstract][Full Text] [Related]
12. t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming.
Kellaway S; Chin PS; Barneh F; Bonifer C; Heidenreich O
Cells; 2020 Dec; 9(12):. PubMed ID: 33322186
[TBL] [Abstract][Full Text] [Related]
13. The chromatin-remodeling factor
Heshmati Y; Türköz G; Harisankar A; Kharazi S; Boström J; Dolatabadi EK; Krstic A; Chang D; Månsson R; Altun M; Qian H; Walfridsson J
Haematologica; 2018 Jul; 103(7):1169-1181. PubMed ID: 29599201
[TBL] [Abstract][Full Text] [Related]
14. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
15. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
Pulikkan JA; Hegde M; Ahmad HM; Belaghzal H; Illendula A; Yu J; O'Hagan K; Ou J; Muller-Tidow C; Wolfe SA; Zhu LJ; Dekker J; Bushweller JH; Castilla LH
Cell; 2018 Jun; 174(1):172-186.e21. PubMed ID: 29958106
[TBL] [Abstract][Full Text] [Related]
16. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
Aubrey BJ; Cutler JA; Bourgeois W; Donovan KA; Gu S; Hatton C; Perlee S; Perner F; Rahnamoun H; Theall ACP; Henrich JA; Zhu Q; Nowak RP; Kim YJ; Parvin S; Cremer A; Olsen SN; Eleuteri NA; Pikman Y; McGeehan GM; Stegmaier K; Letai A; Fischer ES; Liu XS; Armstrong SA
Nat Cancer; 2022 May; 3(5):595-613. PubMed ID: 35534777
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional corepressor CBFA2T3 inhibits all-
Steinauer N; Guo C; Zhang J
J Biol Chem; 2020 Jul; 295(27):8887-8900. PubMed ID: 32434928
[TBL] [Abstract][Full Text] [Related]
18. Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition.
Carter BZ; Mak PY; Tao W; Warmoes M; Lorenzi PL; Mak D; Ruvolo V; Tan L; Cidado J; Drew L; Andreeff M
Haematologica; 2022 Jan; 107(1):58-76. PubMed ID: 33353284
[TBL] [Abstract][Full Text] [Related]
19. The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia.
Roe JS; Vakoc CR
Cold Spring Harb Symp Quant Biol; 2016; 81():61-66. PubMed ID: 28174254
[TBL] [Abstract][Full Text] [Related]
20. Targeting the GFI1/1B-CoREST Complex in Acute Myeloid Leukemia.
van Bergen MGJM; van der Reijden BA
Front Oncol; 2019; 9():1027. PubMed ID: 31649884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
